These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24400637)

  • 41. Plasmodium berghei sporozoites are mitogenic for murine T cells, induce interferon, and activate natural killer cells.
    Ojo-Amaize EA; Vilcek J; Cochrane AH; Nussenzweig RS
    J Immunol; 1984 Aug; 133(2):1005-9. PubMed ID: 6429240
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of in vivo administration of anti-IL-10 or anti-IFN-gamma monoclonal antibody on the host defense mechanism against Plasmodium yoelii yoelii infection.
    Kobayashi F; Ishida H; Matsui T; Tsuji M
    J Vet Med Sci; 2000 Jun; 62(6):583-7. PubMed ID: 10907683
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Host Resistance to Plasmodium-Induced Acute Immune Pathology Is Regulated by Interleukin-10 Receptor Signaling.
    Claser C; De Souza JB; Thorburn SG; Grau GE; Riley EM; Rénia L; Hafalla JCR
    Infect Immun; 2017 Jun; 85(6):. PubMed ID: 28396319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dendritic cells subsets mediated immune response during Plasmodium berghei ANKA and Plasmodium yoelii infection.
    Keswani T; Sengupta A; Sarkar S; Bhattacharyya A
    Cytokine; 2015 Jun; 73(2):198-206. PubMed ID: 25792277
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interleukin-15 enhances innate and adaptive immune responses to blood-stage malaria infection in mice.
    Ing R; Gros P; Stevenson MM
    Infect Immun; 2005 May; 73(5):3172-7. PubMed ID: 15845528
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IL-22 dampens the T cell response in experimental malaria.
    Sellau J; Alvarado CF; Hoenow S; Mackroth MS; Kleinschmidt D; Huber S; Jacobs T
    Sci Rep; 2016 Jun; 6():28058. PubMed ID: 27311945
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of the aryl hydrocarbon receptor in the immune response profile and development of pathology during Plasmodium berghei Anka infection.
    Brant F; Miranda AS; Esper L; Rodrigues DH; Kangussu LM; Bonaventura D; Soriani FM; Pinho V; Souza DG; Rachid MA; Weiss LM; Tanowitz HB; Teixeira MM; Teixeira AL; Machado FS
    Infect Immun; 2014 Aug; 82(8):3127-40. PubMed ID: 24818665
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Toll-like receptor 7 mediates early innate immune responses to malaria.
    Baccarella A; Fontana MF; Chen EC; Kim CC
    Infect Immun; 2013 Dec; 81(12):4431-42. PubMed ID: 24042114
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Toll-like receptor-dependent IL-12 production by dendritic cells is required for activation of natural killer cell-mediated Type-1 immunity induced by Chrysanthemum coronarium L.
    Tanaka S; Koizumi S; Masuko K; Makiuchi N; Aoyagi Y; Quivy E; Mitamura R; Kano T; Ohkuri T; Wakita D; Chamoto K; Kitamura H; Nishimura T
    Int Immunopharmacol; 2011 Feb; 11(2):226-32. PubMed ID: 21144920
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of pro-inflammatory mediators in Plasmodium berghei infected BALB/c mice breaks blood-brain-barrier and leads to cerebral malaria in an IL-12 dependent manner.
    Schmidt KE; Schumak B; Specht S; Dubben B; Limmer A; Hoerauf A
    Microbes Infect; 2011 Sep; 13(10):828-36. PubMed ID: 21609776
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential interleukin-10 expression in interferon regulatory factor-1 deficient mice during Plasmodium berghei blood-stage infection.
    Tan RS; Kara AU; Feng C; Asano Y; Sinniah R
    Parasite Immunol; 2000 Sep; 22(9):425-35. PubMed ID: 10972849
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Natural Killer Cell Sensing of Infected Cells Compensates for MyD88 Deficiency but Not IFN-I Activity in Resistance to Mouse Cytomegalovirus.
    Cocita C; Guiton R; Bessou G; Chasson L; Boyron M; Crozat K; Dalod M
    PLoS Pathog; 2015 May; 11(5):e1004897. PubMed ID: 25954804
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hemozoin-induced IFN-γ production mediates innate immune protection against sporozoite infection.
    Franco A; Flores-Garcia Y; Venezia J; Daoud A; Scott AL; Zavala F; Sullivan DJ
    Microbes Infect; 2024; 26(5-6):105343. PubMed ID: 38670216
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA.
    Palomo J; Fauconnier M; Coquard L; Gilles M; Meme S; Szeremeta F; Fick L; Franetich JF; Jacobs M; Togbe D; Beloeil JC; Mazier D; Ryffel B; Quesniaux VF
    Eur J Immunol; 2013 Oct; 43(10):2683-95. PubMed ID: 23780878
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Natural killer cell intrinsic toll-like receptor MyD88 signaling contributes to IL-12-dependent IFN-γ production by mice during infection with Toxoplasma gondii.
    Ge Y; Chen J; Qiu X; Zhang J; Cui L; Qi Y; Liu X; Qiu J; Shi Z; Lun Z; Shen J; Wang Y
    Int J Parasitol; 2014 Jun; 44(7):475-84. PubMed ID: 24727091
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spatiotemporal requirements for IRF7 in mediating type I IFN-dependent susceptibility to blood-stage Plasmodium infection.
    Edwards CL; Best SE; Gun SY; Claser C; James KR; de Oca MM; Sebina I; Rivera Fde L; Amante FH; Hertzog PJ; Engwerda CR; Renia L; Haque A
    Eur J Immunol; 2015 Jan; 45(1):130-41. PubMed ID: 25319247
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasmodium chabaudi adami: interferon-gamma but not IL-2 is essential for the expression of cell-mediated immunity against blood-stage parasites in mice.
    Batchelder JM; Burns JM; Cigel FK; Lieberg H; Manning DD; Pepper BJ; Yañez DM; van der Heyde H; Weidanz WP
    Exp Parasitol; 2003 Oct; 105(2):159-66. PubMed ID: 14969693
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    Keswani T; Delcroix-Genete D; Herbert F; Leleu I; Lambert C; Draheim M; Salome-Desnoulez S; Saliou JM; Cazenave PA; Silvie O; Roland J; Pied S
    J Immunol; 2020 Dec; 205(11):3071-3082. PubMed ID: 33148715
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of a Novel CD4
    Fernandez-Ruiz D; Lau LS; Ghazanfari N; Jones CM; Ng WY; Davey GM; Berthold D; Holz L; Kato Y; Enders MH; Bayarsaikhan G; Hendriks SH; Lansink LIM; Engel JA; Soon MSF; James KR; Cozijnsen A; Mollard V; Uboldi AD; Tonkin CJ; de Koning-Ward TF; Gilson PR; Kaisho T; Haque A; Crabb BS; Carbone FR; McFadden GI; Heath WR
    J Immunol; 2017 Dec; 199(12):4165-4179. PubMed ID: 29084838
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Type I interferons suppress CD4⁺ T-cell-dependent parasite control during blood-stage Plasmodium infection.
    Haque A; Best SE; Ammerdorffer A; Desbarrieres L; de Oca MM; Amante FH; de Labastida Rivera F; Hertzog P; Boyle GM; Hill GR; Engwerda CR
    Eur J Immunol; 2011 Sep; 41(9):2688-98. PubMed ID: 21674481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.